Suchergebnisse - "van der Plas, Johan L"

PubPharm (12)

1

Causal chemoprophylactic activity of cabamiquine against Plasmodium falciparum in a controlled human malaria infection : a randomised, double-blind, placebo-controlled study in the Netherlands

enthalten in: The Lancet. Infectious diseases | 2023

von van der Plas, J. | Kuiper, V. | Bagchus, W. | +22

CommentIn: Lancet Infect Dis. 2023 Oct;23(10):1102-1103. - PMID 37414067

2

Immunosuppression by hydroxychloroquine : mechanistic proof in in vitro experiments but limited systemic activity in a randomized placebo-controlled clinical pharmacology study

enthalten in: Immunologic research | 2023

von In 't Veld, A. | Grievink, H. | van der Plas, J. | +9

3

Viral clearance, pharmacokinetics and tolerability of ensovibep in patients with mild to moderate COVID-19 : A phase 2a, open-label, single-dose escalation study

enthalten in: British journal of clinical pharmacology | 2023

von Prins, M. | van der Plas, J. | Vissers, M. | +13

4

Immunosuppression by hydroxychloroquine: mechanistic proof in in vitro experiments but limited systemic activity in a randomized placebo-controlled clinical pharmacology study

enthalten in: Immunologic research | 2023

von in ‘t Veld, A. | Grievink, H. | van der Plas, J. | +9

5

Immunosuppression by hydroxychloroquine: mechanistic proof in in vitro experiments but limited systemic activity in a randomized placebo-controlled clinical pharmacology study

enthalten in: Immunologic research | 2023

von in ‘t Veld, A. | Grievink, H. | van der Plas, J. | +9

6

Immunosuppression by hydroxychloroquine: mechanistic proof in in vitro experiments but limited systemic activity in a randomized placebo-controlled clinical pharmacology study

enthalten in: Immunologic research | 2023

von in ‘t Veld, A. | Grievink, H. | van der Plas, J. | +9

7

A Randomized First-in-Human Study With UB-312, a UBITh® α-Synuclein Peptide Vaccine

enthalten in: Movement disorders : official journal of the Movement Disorder Society | 2022

von Yu, H. | Thijssen, E. | van Brummelen, E. | +6

8

Accelerating vaccine trial conduct in a pandemic with a hot spot-based inclusion strategy using trial and epidemic simulation

enthalten in: Clinical and translational science | 2021

von van der Plas, J. | van Esdonk, M. | Kamerling, I. | +1

9

How to expedite early-phase SARS-CoV-2 vaccine trials in pandemic setting-A practical perspective

enthalten in: British journal of clinical pharmacology | 2021

von van der Plas, J. | Roestenberg, M. | Cohen, A. | +1

10

First-in-human administration of a live-attenuated RSV vaccine lacking the G-protein assessing safety, tolerability, shedding and immunogenicity : a randomized controlled trial

enthalten in: Vaccine | 2020

von Verdijk, P. | van der Plas, J. | van Brummelen, E. | +5